Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet. 2016;388(10039):73–85.
Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A. Pancreatic cancer: Advances and challenges. Cell. 2023;186(8):1729–54.
Cai J, Chen H, Lu M, Zhang Y, Lu B, You L, et al. Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis. Cancer Lett. 2021;520:1–11.
Ducreux M, ASA Cuhna, Caramella C, Hollebecque A, Burtin P, Goéré D, et al. Cancer of the pancreas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26:v56-68.
Moffat GT, Epstein AS, O’Reilly EM. Pancreatic cancer—A disease in need: optimizing and integrating supportive care. Cancer. 2019;125(22):3927–35.
Partelli S, Sclafani F, Barbu ST, Beishon M, Bonomo P, Braz G, de Braud F, Brunner T, Cavestro GM, Crul M, Trill MD. European cancer organisation essential requirements for quality cancer care (ERQCC): pancreatic cancer. Cancer Treat Rev. 2021;99:102208.
Prades J, Arnold D, Brunner T, Cardone A, Carrato A, Coll-Ortega C, et al. Bratislava statement: consensus recommendations for improving pancreatic cancer care. ESMO Open. 2020;5(6):e001051.
Law B, Windsor J, Connor S, Koea J, Srinivasa S. Best supportive care in advanced pancreas cancer: a systematic review to define a patient-care bundle. ANZ J Surg. 2024;94(7–8):1254–9.
Wood LD, Canto MI, Jaffee EM, Simeone DM. Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment. Gastroenterology. 2022;163(2):386-402.e1.
Principe DR, Underwood PW, Korc M, Trevino JG, Munshi HG, Rana A. The current treatment paradigm for pancreatic ductal adenocarcinoma and barriers to therapeutic efficacy. Front Oncol. 2021;15:11.
Bengtsson A, Andersson R, Ansari D. The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data. Sci Rep. 2020;10(1):16425.
Kleeff J, Korc M, Apte M, La Vecchia C, Johnson CD, Biankin AV, et al. Pancreatic cancer. Nat Rev Dis Primers. 2016;2(1):16022.
Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020;395(10242):2008–20.
Griffin OM, Bashir Y, O’Connor D, Peakin J, McMahon J, Duggan SN, et al. Measurement of body composition in pancreatic cancer: a systematic review, meta-analysis, and recommendations for future study design. Dig Surg. 2022;39(4):141–52.
O’Connor D, Brown M, Eatock M, Turkington RC, Prue G. Exercise efficacy and prescription during treatment for pancreatic ductal adenocarcinoma: a systematic review. BMC Cancer. 2021;21(1):43.
Kordes M, Larsson L, Engstrand L, Löhr JM. Pancreatic cancer cachexia: three dimensions of a complex syndrome. Br J Cancer. 2021;124(10):1623–36.
Bargetzi L, Brack C, Herrmann J, Bargetzi A, Hersberger L, Bargetzi M, et al. Nutritional support during the hospital stay reduces mortality in patients with different types of cancers: secondary analysis of a prospective randomized trial. Ann Oncol. 2021;32(8):1025–33.
Capurso G, Pecorelli N, Burini A, Orsi G, Palumbo D, Macchini M, et al. The impact of nutritional status on pancreatic cancer therapy. Expert Rev Anticancer Ther. 2022;22(2):155–67.
Mikkelsen MK, Juhl CB, Lund CM, Jarden M, Vinther A, Nielsen DL. The effect of exercise-based interventions on health-related quality of life and physical function in older patients with cancer receiving medical antineoplastic treatments: a systematic review. Eur Rev Aging Phys Act. 2020;17(1):18.
Buffart LM, Kalter J, Sweegers MG, Courneya KS, Newton RU, Aaronson NK, et al. Effects and moderators of exercise on quality of life and physical function in patients with cancer: an individual patient data meta-analysis of 34 RCTs. Cancer Treat Rev. 2017;52:91–104.
Cormie P, Spry N, Jasas K, Johansson M, Yusoff I, Newton R, et al. Exercise as medicine in the management of pancreatic cancer: a case study. Med Sci Sports Exerc. 2014;46(4):664–70. Available from: https://www.semanticscholar.org/paper/34d439574869254e761150c76a52ce6db2f29349
Ngo-Huang A, Parker NH, Bruera E, Lee RE, Simpson R, O’Connor DP, et al. Home-based exercise prehabilitation during preoperative treatment for pancreatic cancer is associated with improvement in physical function and quality of life. Integr Cancer Ther. 2019. https://doi.org/10.1177/1534735419894061.
Yeo T, Burrell SA, Sauter P, Kennedy E, Lavu H, Leiby B, et al. A progressive postresection walking program significantly improves fatigue and health-related quality of life in pancreas and periampullary cancer patients. J Am Coll Surg. 2012;214(4):463–75 discussion 475–7. Available from: https://www.semanticscholar.org/paper/7a0f27db335ee336093dc17d5b9018b0319cfde8.
Arthur AE, Delk A, Demark-Wahnefried W, Christein JD, Contreras C, Posey JA, et al. Pancreatic cancer survivors’ preferences, barriers, and facilitators related to physical activity and diet interventions. J Cancer Surviv. 2016;10(6):981–9.
Ester M, Culos-Reed SN, Abdul-Razzak A, Daun JT, Duchek D, Francis G, et al. Feasibility of a multimodal exercise, nutrition, and palliative care intervention in advanced lung cancer. BMC Cancer. 2021;21(1):159.
Safyan RA, Kim E, Dekker E, Homs M, Aguirre AJ, Koerkamp BG, et al. Multidisciplinary standards and evolving therapies for patients with pancreatic cancer. Am Soc Clin Oncol Educ Book. 2024. https://doi.org/10.1200/EDBK_438598.
Fonseca AL, Khan H, Mehari KR, Cherla D, Heslin MJ, Johnston FM. Disparities in access to oncologic care in pancreatic cancer: a systematic review. Ann Surg Oncol. 2022;29(5):3232–50.
Damm M, Weniger M, Kölsch AK, Lampert C, Ceyhan GO, Beer S, et al. The quality of pain management in pancreatic cancer: a prospective multi-center study. Pancreatology. 2020;20(7):1511–8.
Marthick M, McGregor D, Alison J, Cheema B, Dhillon H, Shaw T. Supportive care interventions for people with cancer assisted by digital technology: systematic review. J Med Internet Res. 2021;23(10):e24722.
Tripepi M, Pizzocaro E, Giardino A, Frigerio I, Guglielmi A, Butturini G. Telemedicine and pancreatic cancer: a systematic review. Telemedicine and e-Health. 2023;29(3):352–60.
Steindal SA, Nes AAG, Godskesen TE, Dihle A, Lind S, Winger A, et al. Patients’ experiences of telehealth in palliative home care: scoping review. J Med Internet Res. 2020;22(5):e16218.
Shaffer KM, Turner KL, Siwik C, Gonzalez BD, Upasani R, Glazer JV, et al. Digital health and telehealth in cancer care: a scoping review of reviews. Lancet Digit Health. 2023;5(5):e316–27.
Ancona C, Caroppo E, De Lellis P. Digital solutions supporting the quality-of-life of European cancer patients and their caregivers: a systematic literature review. Health Technol (Berl). 2025;15(2):243–72.
van Kessel R, Roman-Urrestarazu A, Anderson M, Kyriopoulos I, Field S, Monti G, et al. Mapping factors that affect the uptake of digital therapeutics within health systems: scoping review. J Med Internet Res. 2023;25(25):e48000.
Kuziemsky C, Maeder AJ, John O, Gogia SB, Basu A, Meher S, et al. Role of artificial intelligence within the telehealth domain. Yearb Med Inform. 2019;28(01):035–40.
Tait RC, Chibnall JT, Krause S. The pain disability index: psychometric properties. Pain. 1990;40(2):171–82.
Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017;36(5):1187–96.Available from: https://linkinghub.elsevier.com/retrieve/pii/S0261561417302285
Muscaritoli M, Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, et al. ESPEN practical guideline: Clinical Nutrition in cancer. Clin Nutr. 2021;40(5):2898–913. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0261561421000790
Cederholm T, Jensen GL, Correia MITD, Gonzalez MC, Fukushima R, Higashiguchi T, et al. GLIM criteria for the diagnosis of malnutrition – A consensus report from the global clinical nutrition community. Clin Nutr. 2019;38(1):1–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S026156141831344X
Ottery F. Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition. 1996;12:S15–9.
Jager-Wittenaar H, Ottery FD. Assessing nutritional status in cancer. Curr Opin Clin Nutr Metab Care. 2017;20(5):322–9. Available from: https://journals.lww.com/00075197-201709000-00004
Dewansingh P, Euwes M, Krijnen WP, Strijbos JH, van der Schans CP, Jager-Wittenaar H. Patient-generated subjective global assessment short form better predicts length of stay than short nutritional assessment questionnaire. Nutrition. 2021;91–92:111366. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0899900721002288
Bouëtté G, Esvan M, Apel K, Thibault R. A visual analogue scale for food intake as a screening test for malnutrition in the primary care setting: prospective non-interventional study. Clin Nutr. 2021;40(1):174–80. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0261561420302168
Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-Country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.
Warburton DER, Jamnik V, Bredin SSD, Gledhill N. The 2014 Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) and electronic Physical Activity Readiness Medical Examination (ePARmed-X+). Health Fit J Canada. 2014;7(1):80–3. Available from: http://www.healthandfitnessjournalofcanada.com/index.php/html/article/view/171
Schmidt K, Vogt L, Thiel C, Jäger E, Banzer W. Validity of the six-minute walk test in cancer patients. Int J Sports Med. 2013;34(7):631–6.
van Cappellen-van Maldegem SJM, Hoedjes M, Seidell JC, van de Poll-Franse LV, Buffart LM, Mols F, et al. Self-performed Five Times Sit-To-Stand test at home as (pre-)screening tool for frailty in cancer survivors: Reliability and agreement assessment. J Clin Nurs. 2021;2022:1–11.
Goldberg A, Chavis M, Watkins J, Wilson T. The five-times-sit-to-stand test: validity, reliability and detectable change in older females. Aging Clin Exp Res. 2012;24(4):339–44.
Zhuang CL, Zhang FM, Li W, Wang KH, Xu HX, Song CH, et al. Associations of low handgrip strength with cancer mortality: a multicentre observational study. J Cachexia Sarcopenia Muscle. 2020;11(6):1476–86.
Kilgour RD, Vigano A, Trutschnigg B, Lucar E, Borod M, Morais JA. Handgrip strength predicts survival and is associated with markers of clinical and functional outcomes in advanced cancer patients. Support Care Cancer. 2013;21(12):3261–70.
Horak FB, Wrisley DM, Frank J. The Balance Evaluation Systems Test (BESTest) to Differentiate Balance Deficits. Phys Ther. 2009;89(5):484–98. Available from: https://academic.oup.com/ptj/article/89/5/484/2737639
Viveiro LAP, Gomes GCV, Bacha JMR, Carvas Junior N, Kallas ME, Reis M, et al. Reliability, Validity, and Ability to Identity Fall Status of the Berg Balance Scale, Balance Evaluation Systems Test (BESTest), Mini-BESTest, and Brief-BESTest in Older Adults Who Live in Nursing Homes. J Geriatr Phys Ther. 2019;42(4):E45-54. Available from: https://doi.org/10.1519/JPT.0000000000000215.
Neuzillet C, Vergnault M, Bonnetain F, Hammel P. Rationale and design of the Adapted Physical Activity in advanced Pancreatic Cancer patients (APACaP) GERCOR (Groupe Coopérateur Multidisciplinaire en Oncologie) trial: study protocol for a randomized controlled trial. Trials. 2015;16:454.
Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, GALVÃO DA, Pinto BM, et al. American college of sports medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010;42(7):1409–26. Available from: https://journals.lww.com/00005768-201007000-00023
Avancini A, Borsati A, Trestini I, Tregnago D, Belluomini L, Sposito M, et al. Exploring the feasibility of a combined exercise program for patients with advanced lung or pancreatic cancer. Asia Pac J Oncol Nurs. 2023;10:100298. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2347562523001166
Naito T, Mitsunaga S, Miura S, Tatematsu N, Inano T, Mouri T, et al. Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer. J Cachexia Sarcopenia Muscle. 2018;10:73–83. Available from: https://www.semanticscholar.org/paper/f8d82e95b66f8a13fd66847743bb35acb7baa0c1
Solheim TS, Laird BJA, Balstad TR, Stene GB, Bye A, Johns N, et al. A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer. J Cachexia Sarcopenia Muscle. 2017;8(5):778–88.
Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle. 2016;7(1):28–36.
Waldmann A, Schubert D, Katalinic A. Normative data of the EORTC QLQ-C30 for the german population: a population-based survey. PLoS ONE. 2013;8(9):e74149.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology. J Nal Cancer Instit. 1993;85(5):365–76. Available from: https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnci/85.5.365
Fayers P, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A. EORTC QLQ-C30 Scoring Manual. 3rd ed. Brussels: European Organisation for Research and Treatment of Cancer; 2001.
Bijur PE, Latimer CT, Gallagher EJ. Validation of a verbally administered numerical rating scale of acute pain for use in the emergency department. Acad Emerg Med. 2003;10(4):390–2. Available from:https://onlinelibrary.wiley.com/doi/10.1111/j.1553-2712.2003.tb01355.x
Thibault R, Goujon N, Le Gallic E, Clairand R, Sébille V, Vibert J, et al. Use of 10-point analogue scales to estimate dietary intake: A prospective study in patients nutritionally at-risk. Clin Nutr. 2009;28(2):134–40. Available from: https://linkinghub.elsevier.com/retrieve/pii/S026156140900017X
Landers A, McKenzie C, Pitama SG, Brown H. Enzyme replacement in advanced pancreatic cancer: patient perceptions. BMJ Support Palliat Care. 2023;13(e1):e122–8.
Pezzilli R, Caccialanza R, Capurso G, Brunetti O, Milella M, Falconi M. Pancreatic Enzyme replacement therapy in pancreatic cancer. Cancers (Basel). 2020;12(2):275.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–117.
Peterson SJ, Mozer M. Differentiating sarcopenia and cachexia among patients with cancer. Nutr Clin Pract. 2017;32(1):30–9.
Duncan RP, Leddy AL, Cavanaugh JT, Dibble LE, Ellis TD, Ford MP, et al. Comparative Utility of the BESTest, Mini-BESTest, and Brief-BESTest for Predicting Falls in Individuals With Parkinson Disease: A Cohort Study. Phys Ther. 2013;93(4):542–50. Available from: https://academic.oup.com/ptj/article/93/4/542/2735443
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30312372
Desramé J, Baize N, Anota A, Laribi K, Stefani L, Hjiej S, et al. Fatigue visual analogue scale score correlates with quality of life in cancer patients receiving epoetin alfa (Sandoz) for chemotherapy-induced anaemia: the CIROCO study. Cancer Treat Res Commun. 2023;37:100781.
Gräßel E, Chiu T, Oliver R. Development and validation of the Burden Scale for Family Caregivers (BSFC). Toronto: COTA Comprehensive Rehabilitation and Mental Health Services; 2003.
Wercholuk AN, Parikh AA, Snyder RA. The road less traveled: transportation barriers to cancer care delivery in the rural patient population. JCO Oncol Pract. 2022;18(9):652–62.
Kamdar M, Jethwani K, Centi AJ, Agboola S, Fischer N, Traeger L, et al. A Digital Therapeutic Application (ePAL) to Manage pain in patients with advanced cancer: a randomized controlled trial. J Pain Symptom Manage. 2024;68(3):261–71.
Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318(2):197.
Turner K, Kim DW, Gonzalez BD, Gore LR, Gurd E, Milano J, et al. Support Through Remote Observation and Nutrition Guidance (STRONG), a digital health intervention to reduce malnutrition among pancreatic cancer patients: A study protocol for a pilot randomized controlled trial. Contemp Clin Trials Commun. 2024;1:38.
Neuzillet C, Bouché O, Tournigand C, Chibaudel B, Bauguion L, Bengrine-Lefevre L, et al. Effect of adapted physical activity in patients with advanced pancreatic cancer: The APACaP GERCOR Randomized Trial. J Natl Compr Cancer Netw. 2023;21(12):1234–42.
Luo H, Galvão DA, Newton RU, Tang CI, Spry N, Taaffe DR. Multimodal Exercise in older patients with advanced pancreatic cancer undergoing first-line chemotherapy: a case series examining feasibility and preliminary efficacy. Eur J Cancer Care. 2023;(1):1179848.
Gresham G, Liu E, Diniz MA, Barnhill K, Nikravesh N, Welborn A, et al. Association between remotely-monitored activity, patient-reported outcomes, and physical function in patients with advanced pancreatic cancer. J Clin Oncol. 2022;40(16_suppl):1572–1572.
Galvin R, Chung C, Achenbach E, Dziadkowiec O, Sen S. Barriers to clinical trial enrollment in patients with pancreatic adenocarcinoma eligible for early-phase clinical trials. Oncology (Williston Park). 2020;34(10):407–12.
Luo H, Galvão DA, Newton RU, Tang C, Dean A, Jasas K, et al. Feasibility and efficacy of a multicomponent exercise medicine programme in patients with pancreatic cancer undergoing neoadjuvant therapy (the EXPAN trial): study protocol of a dual-centre, two-armed phase I randomised controlled trial. BMJ Open Gastroenterol. 2021. https://doi.org/10.1136/bmjgast-2021-000642.
Henderson NL, Ortiz-Olguin E, Bourne G, Pywell C, Rose JB, Williams GR, et al. Implementation of ePROs into multidisciplinary tumor board discussions for patients with pancreatic cancer: The INSPIRE Intervention. J Natl Compr Canc Netw. 2024;22(9):602–9.
Cobianchi L, Dal Mas F, Pizzocaro E, Tripepi M, Butturini G. Co-design, co-learning, and co-production of an app for pancreatic cancer patients—the “Pancreas Plus” study protocol. Mhealth. 2023;9:16–16.
Mi N, Zhang S, Sun X, Li T, Liao Y, Dong L, et al. A Randomized Controlled Trial of Mindfulness Meditation Combined With BrainLink Intelligent Biofeedback Instrument on Pancreatic Cancer Patients Under Chemotherapy. Brain Behav. 2024;14(12):e70197.
Anderson T, Prue G, McDowell G, Stark P, Brown Wilson C, Graham Wisener L, et al. Co-design and evaluation of a digital serious game to promote public awareness about pancreatic cancer. BMC Public Health. 2024;24(1):570.